Literature DB >> 9918699

The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells.

W A Pedersen1, N R Cashman, M P Mattson.   

Abstract

Both oxidative stress and excitotoxicity are implicated in the pathogenesis of a number of neurodegenerative disorders, such as amyotrophic lateral sclerosis. We previously reported increased modification of proteins by 4-hydroxynonenal (HNE), a product of membrane lipid peroxidation, in the spinal cords of patients with amyotrophic lateral sclerosis relative to controls. In the current study, we examined the functional consequences of protein modification by HNE in a cell line with a motor neuron phenotype, NSC-19. Treatment of NSC-19 cells with FeSO4, which catalyzes lipid peroxidation, or HNE induced concentration-dependent decreases in glucose and glutamate transport. Vitamin E and propyl gallate blocked the impairment of glucose and glutamate transport caused by FeSO4 in these cells, but not that caused by HNE, whereas glutathione blocked the effects of FeSO4 as well as HNE. Both FeSO4 and HNE caused an increase in the number of apoptotic nuclei in NSC-19 cultures, but this occurred subsequent to the impairment of glucose and glutamate transport. Reductions in choline acetyltransferase activity were also observed in FeSO4- or HNE-treated NSC-19 cells before induction of apoptosis. Our results suggest that, prior to cell death, oxidative stress and HNE down-regulate cholinergic markers and impair glucose and glutamate transport in motor neurons, the latter of which may lead to excitotoxic degeneration of the cells. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9918699     DOI: 10.1006/exnr.1998.6890

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  21 in total

1.  Evidence that hyperprolinemia alters glutamatergic homeostasis in rat brain: neuroprotector effect of guanosine.

Authors:  Andréa G K Ferreira; Aline A da Cunha; Emilene B Scherer; Fernanda R Machado; Maira J da Cunha; Andressa Braga; Ben Hur Mussulini; Júlia D Moreira; Susana Wofchuk; Diogo O Souza; Angela T S Wyse
Journal:  Neurochem Res       Date:  2011-09-21       Impact factor: 3.996

2.  Chronic Treatment with a Clinically Relevant Dose of Methylphenidate Increases Glutamate Levels in Cerebrospinal Fluid and Impairs Glutamatergic Homeostasis in Prefrontal Cortex of Juvenile Rats.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Daniella M Coelho; Ben Hur Mussulini; Mery S L Pereira; Mariana M Parisi; Florencia Barbé-Tuana; Diogo L de Oliveira; Carmen R Vargas; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2015-05-24       Impact factor: 5.590

3.  Pharmacological inhibition of lipid peroxidation attenuates calpain-mediated cytoskeletal degradation after traumatic brain injury.

Authors:  Ayman G Mustafa; Juan A Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2011-03-22       Impact factor: 5.372

Review 4.  4-Hydroxy-2-nonenal, a reactive product of lipid peroxidation, and neurodegenerative diseases: a toxic combination illuminated by redox proteomics studies.

Authors:  Marzia Perluigi; Raffaella Coccia; D Allan Butterfield
Journal:  Antioxid Redox Signal       Date:  2012-02-15       Impact factor: 8.401

5.  Methylphenidate Decreases ATP Levels and Impairs Glutamate Uptake and Na+,K+-ATPase Activity in Juvenile Rat Hippocampus.

Authors:  Felipe Schmitz; Paula Pierozan; André F Rodrigues; Helena Biasibetti; Mateus Grings; Bruna Zanotto; Daniella M Coelho; Carmen R Vargas; Guilhian Leipnitz; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

6.  Mitochondrial protection after traumatic brain injury by scavenging lipid peroxyl radicals.

Authors:  Ayman G Mustafa; Indrapal N Singh; Juan Wang; Kimberly M Carrico; Edward D Hall
Journal:  J Neurochem       Date:  2010-04-16       Impact factor: 5.372

7.  Involvement of 4-hydroxy-2-nonenal accumulation in multiple system atrophy.

Authors:  Noriyuki Shibata; Yuri Inose; Sono Toi; Atsuko Hiroi; Tomoko Yamamoto; Makio Kobayashi
Journal:  Acta Histochem Cytochem       Date:  2010-04-21       Impact factor: 1.938

Review 8.  Lipid peroxidation triggers neurodegeneration: a redox proteomics view into the Alzheimer disease brain.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Free Radic Biol Med       Date:  2012-10-05       Impact factor: 7.376

9.  Involvement of Maillard reactions in Alzheimer disease.

Authors:  V Prakash Reddy; Mark E Obrenovich; Craig S Atwood; George Perry; Mark A Smith
Journal:  Neurotox Res       Date:  2002-05       Impact factor: 3.911

10.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.